Kikumoto R, Tobe A, Fukami H, Ninomiya K, Egawa M
J Med Chem. 1984 May;27(5):645-9. doi: 10.1021/jm00371a015.
A series of substituted (omega- aminoalkoxy )stilbene derivatives has been synthesized and screened for anticonvulsant activity. The effect of structural modification of these molecules on the activities has been systematically examined. Potent anticonvulsant activity was displayed by 2-[4-(4-methyl-1 piperazinyl)butoxy]stilbene (20) and some 2-[4-(3-alkoxy-1-piperidino)butoxy]stilbene derivatives (21, 37, 38, and 40), as determined by maximal electroshock seizure (MES) and pentylenetetrazol-induced convulsion tests in mice. Compound 21 exhibited more potent anti-MES activity than diphenylhydantoin and carbamazepine in further pharmacological tests in rats, and its therapeutic index was superior to those of two antiepileptic drugs.
已合成了一系列取代的(ω-氨基烷氧基)芪衍生物,并对其抗惊厥活性进行了筛选。系统研究了这些分子的结构修饰对活性的影响。通过小鼠最大电休克惊厥(MES)和戊四氮诱导惊厥试验确定,2-[4-(4-甲基-1-哌嗪基)丁氧基]芪(20)和一些2-[4-(3-烷氧基-1-哌啶基)丁氧基]芪衍生物(21、37、38和40)显示出强效抗惊厥活性。在大鼠的进一步药理试验中,化合物21表现出比苯妥英和卡马西平更强的抗MES活性,其治疗指数优于两种抗癫痫药物。